* Patient can try NITYR for 30 days, one-time, for free, as long as their doctor prescribes it and that have never used NITYR before. Subject to terms and conditions, eligibility criteria, and other federal and state law.

See offer

* For eligible commercially insured patients. Doctor’s prescription required. Subject to terms and conditions and eligibility criteria. Program not available for government-insured patients and subject to other federal and state law.

See offer
+
This site is intended for US consumers NITYR Back to top
NITYR Enrollment Form
Language: English (EN)
Español (ES)
Safety InformationPrescribing Information
Safety InformationPrescribing Information

Navigating a New Diagnosis

Many parents report feeling overwhelmed when their child is diagnosed with hereditary tyrosinemia type 1 (HT-1). If your child is newly diagnosed with HT-1, talk with your healthcare professional about all your treatment options. With your help, your child can lead a full life. And with NITYR there is one less thing for you to worry about.

If you are considering NITYR, speak to your HCP, your dietitian or your clinic today – you don’t need to wait until your next appointment. To help you get the most out of the discussion, we’ve gathered some common questions to ask your HCP. Simply download the guide here.

Giving NITYR to Alina is very simple, says Alina's Father.
It's very small1, it's tasteless and in the future it will be easier for Alina to swallow it.
There's nothing to worry about. My daughter has been taking it from day one.

Mohammed - Father of Alina, NITYR patient


NITYR is formulated aiming for convenience. Children as young as three years old may be able to swallow NITYR, but for those infants unable to swallow a tablet, NITYR can be used to create a tasteless suspension. The suspension can be administered via oral syringe and is a simple and clean process, which might make your life easier. The tablets can be easily disintegrated in an oral syringe2 and the preparation can be kept in the syringe for up to 24 hours, giving you plenty of time to decide when is the right time to give the medication to your child.

NITYR is also stable3 at room temperature between 68° to 77°F (20° to 25°C), allowing for excursions between 59° and 86°F (15° and 30°C), freeing you up from having to refrigerate the medication and reducing the chance of toxic impurities forming. It has a shelf life of 36 months (3 years). To help families facing dietary restrictions every day, the new formulation can also be taken with or without food.

Professional Support When You Need It

Cycle Pharmaceuticals is an ongoing resource for parents and caregivers, and we are here for you every step of the way.

Parents and family members can access our specialized NITYR Patient Liaison Services. We know that questions sometimes come up during an overnight feed. Our Patient Liaison Services Team provides access to a pharmacist to give you the best available advice whenever you need help.

We can even offer tips for things like preparing and packing food for a family weekend getaway, for ‘play dates’ or when you plan to leave your child with a babysitter.

1 Data on file: NIT/03/18. 2 Data on file: NIT/01/19. 3 Data on file: NIT/01/20.

Please contact the NITYR Patient Liaison Services for more information:

1-800-775-5783

HT-1 Explained

If your baby or child is newly diagnosed with hereditary tyrosinemia type 1 (HT-1), you probably received a lot of information at once. Even so, a rare ...

FAQs

If you have questions about NITYR, you are not alone. We have compiled some Frequently Asked Questions (FAQs) to help, but if you have any other questions...

Why NITYR?

NITYR (nitisinone) Tablets are the new option to treat babies, adolescents and adults with hereditary tyrosinemia type 1 (HT-1). This new option gives ...

NITYR
Are you a US patient?

(Es usted un Paciente/familiar residente en Estados Unidos?)

NO * YES (Sí)

* If you select "no" then you will be directed to the Cycle Pharmaceuticals website.

By continuing to use this site you are accepting our cookie policy OK
x OPEN

Sign up For Updates

I am a